Ramírez Washington, Pillajo Verónica, Ramírez Eileen, Manzano Ibeth, Meza Doris
Departamento de Ciencias de la Computación, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui S/N, Sangolquí 171104, Ecuador.
Departamento de Informática, Universidad Politécnica Salesiana, Quito 170146, Ecuador.
Sensors (Basel). 2024 Dec 9;24(23):7868. doi: 10.3390/s24237868.
This paper offers a systematic review of advancements in electronic nose technologies for early cancer detection with a particular focus on the detection and analysis of volatile organic compounds present in biomarkers such as breath, urine, saliva, and blood. Our objective is to comprehensively explore how these biomarkers can serve as early indicators of various cancers, enhancing diagnostic precision and reducing invasiveness. A total of 120 studies published between 2018 and 2023 were examined through systematic mapping and literature review methodologies, employing the PICOS (Population, Intervention, Comparison, Outcome, and Study design) methodology to guide the analysis. Of these studies, 65.83% were ranked in Q1 journals, illustrating the scientific rigor of the included research. Our review synthesizes both technical and clinical perspectives, evaluating sensor-based devices such as gas chromatography-mass spectrometry and selected ion flow tube-mass spectrometry with reported incidences of 30 and 8 studies, respectively. Key analytical techniques including Support Vector Machine, Principal Component Analysis, and Artificial Neural Networks were identified as the most prevalent, appearing in 22, 24, and 13 studies, respectively. While substantial improvements in detection accuracy and sensitivity are noted, significant challenges persist in sensor optimization, data integration, and adaptation into clinical settings. This comprehensive analysis bridges existing research gaps and lays a foundation for the development of non-invasive diagnostic devices. By refining detection technologies and advancing clinical applications, this work has the potential to transform cancer diagnostics, offering higher precision and reduced reliance on invasive procedures. Our aim is to provide a robust knowledge base for researchers at all experience levels, presenting insights on sensor capabilities, metrics, analytical methodologies, and the transformative impact of emerging electronic nose technologies in clinical practice.
本文对用于早期癌症检测的电子鼻技术进展进行了系统综述,特别关注生物标志物(如呼吸、尿液、唾液和血液)中挥发性有机化合物的检测和分析。我们的目标是全面探索这些生物标志物如何作为各种癌症的早期指标,提高诊断精度并减少侵入性。通过系统映射和文献综述方法,对2018年至2023年间发表的120项研究进行了审查,采用PICOS(人群、干预措施、对照、结局和研究设计)方法来指导分析。在这些研究中,65.83%发表于Q1区期刊,这表明所纳入研究具有科学严谨性。我们的综述综合了技术和临床观点,评估了基于传感器的设备,如气相色谱 - 质谱联用仪和选择离子流管 - 质谱联用仪,其报道的研究数量分别为30项和8项。包括支持向量机、主成分分析和人工神经网络在内的关键分析技术被确定为最普遍的技术,分别出现在22项、24项和13项研究中。虽然检测准确性和灵敏度有了显著提高,但在传感器优化、数据整合以及临床应用适配方面仍存在重大挑战。这一全面分析弥补了现有研究空白,为无创诊断设备的开发奠定了基础。通过完善检测技术和推进临床应用,这项工作有可能改变癌症诊断方式,提供更高的精度并减少对侵入性程序的依赖。我们的目标是为所有经验水平的研究人员提供一个强大的知识库,展示关于传感器能力、指标、分析方法以及新兴电子鼻技术在临床实践中的变革性影响的见解。